COACTIN Drug Patent Profile
✉ Email this page to a colleague
When do Coactin patents expire, and when can generic versions of Coactin launch?
Coactin is a drug marketed by Roche and is included in one NDA.
The generic ingredient in COACTIN is amdinocillin. There are three drug master file entries for this compound. Additional details are available on the amdinocillin profile page.
Summary for COACTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 3,766 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COACTIN at DailyMed |
US Patents and Regulatory Information for COACTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-003 | Dec 21, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-001 | Dec 21, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | COACTIN | amdinocillin | INJECTABLE;INJECTION | 050565-002 | Dec 21, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |